You have 9 free searches left this month | for more free features.

HPV positive pelvic cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oropharynx Squamous Cell Carcinoma Trial (Blood sample)

Not yet recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Blood sample
  • (no location specified)
Jan 12, 2023

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Blood test for HPV DNA
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • cisplatin, gemcitabine
  • Follow-up
  • Sao Paulo, Brazil
    Hospital do Coração - Research Institute
Mar 1, 2023

Cervical Precancer in HPV-positive Women

Recruiting
  • HPV Infection
  • Cervical Cancer
  • HPV integration test
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College Huazhong University of S
Oct 5, 2022

Self-collected Vaginal and Urine Samples in HIV-positive Women

Not yet recruiting
  • HIV Infections
  • +3 more
  • Self-sampling for HPV infection
  • (no location specified)
Mar 13, 2023

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New

Completed
  • Head and Neck Cancer
  • +2 more
  • ADXS11-001 (ADXS-HPV)
  • New York, New York
  • +1 more
Sep 9, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal HPV-Positive Squamous Cell Carcinoma

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Oropharyngeal HPV-Positive Squamous Cell Carcinoma
  • Radiation Therapy
  • Atlanta, Georgia
  • +1 more
Jun 7, 2022

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

HPV, Oropharyngeal Cancer Trial in Houston (Balstilimab)

Not yet recruiting
  • HPV
  • Oropharyngeal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Using Human Papillomavirus DNA Testing to Detect HPV-Related

Recruiting
  • Oropharyngeal Cancer
  • +2 more
  • NavDx
  • Basking Ridge, New Jersey
  • +6 more
Apr 3, 2023

Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)

Recruiting
  • Cancer of the Head and Neck
  • +3 more
  • Cisplatin injection
  • Columbia, Missouri
    University of Missouri
Oct 31, 2022

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

Not yet recruiting
  • Cervical Cancer
  • +6 more
  • Fludarabine + Cyclophosphamide
  • HRYZ-T101 TCR-T Cell
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

De-escaLated Head and Neck Irradiation in HPV positivE

Recruiting
  • Oropharyngeal Cancer
    • Fargo, North Dakota
    • +1 more
    Nov 14, 2022

    Malignant Tumors of Ill-defined Secondary and Unspecified Sites, Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal

    Terminated
    • Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 22, 2022

    HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin

    Recruiting
    • HPV Positive Oropharyngeal Squamous Cell Carcinoma
    • Cisplatin-based Radiation Therapy
    • Cisplatin Chemotherapy
    • Beverly Hills, California
    • +3 more
    Jul 6, 2022

    HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))

    Recruiting
    • HPV Positive Oropharyngeal Squamous Cell Carcinoma
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Nov 4, 2022

    Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

    Not yet recruiting
    • Head and Neck Cancer
    • +20 more
    • TSC-204-A0201
    • +4 more
    • Scottsdale, Arizona
    • +1 more
    Aug 3, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Apr 20, 2022

    Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

    Terminated
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • RPTR-168
    • Scottsdale, Arizona
    • +3 more
    Dec 2, 2022